Product Support
Find a Clinic

Book your introductory tinnitus call now

Avoid lengthy waiting lists by booking your introductory call with Neuromod Medical now and advance to an assessment within days.

Healthcare Professionals. Learn more about prescribing Lenire.

Interested in Treating Your Patients with Lenire?

Complete this form and a member of our team will follow up to discuss providing Lenire in your clinic.

Patient Suitability:

All patients should be aware of the contraindications for treatment with Lenire. This is a set of conditions by which treatment is not recommended for patients that have one or more of the conditions.


Patients should not use Lenire® if:

-They have a pacemaker, defibrillator or any other active implantable device.
-They are pregnant, unless directed by a doctor.
-They suffer from epilepsy or any other condition that may result in loss of consciousness.
-They suffer from any condition that causes impaired sensitivity of the tongue.
-They have lesions, sores or inflammation of the oral cavity.

Lenire Fitting Range

Please note that some patients with severe hearing loss may not be eligible for Lenire. Lenire cannot be configured if a patients has a hearing threshold (AC) in either ear of >40dBHL in the range of 250Hz – 1kHz or >80dBHL in the range of 2kHz- 8kHz.

Clinical Trials

Tinnitus Alleviation Via Sensory Stimulation:
Safety and Feasibility Study, 60 participants

Visit ClinicalTrials.gov

Treatment Evaluation of Neuromodulation for Tinnitus Stage 1(TENT-A)
Double-blinded randomized trial, 326 participants.

Visit ClinicalTrials.gov

Treatment Evaluation of Neuromodulation for Tinnitus Stage A2 (TENT-A2)
Double-blinded randomized trial, 191 participants.

Visit ClinicalTrials.gov

Check out our published papers

Find our published papers, webinars, patients stories, and more in our dedicated tinnitus reasources section.

View our Resources

Want to order materials for your clinic?

Request Lenire materials for your clinic and your tinnitus patients

Order materials

Subscribe to our Healthcare Newsletter

Our dedicated newsletter for healthcare professionals will keep you up to date with the Lenire treatment and research.